DRUGS/INDICATION
|
CHILDREN |
ADULTS |
acute onset
epinephrine (IM)
|
0.01 mg/kg (as a 1:1000 solution) IM
every 5-15 minutes, maximum 0.3 mg/dose;
|
0.3 to 0.5 mg (as a 1:1000 solution) IM every 5-15 minutes |
cardiopulmonary arrest
epinephrine (IV)
severe hypotension
epinephrine (IV)
|
children: 0.01 mg/kg (as a 1:10,000
solution) intravenously every 3-5 minutes, maximum 1 mg/dose;
|
1 mg (as a 1:10,000 solution) intravenously every 3-5 minutes |
children: 0.01 mg/kg (as a 1:10,000
solution) intravenously every 5 minutes, maximum 0.3 mg/dose;
|
0.1 mg (as a 1:10,000 solution) intravenously every 5 minutes |
|
Adjunct severe hypotension |
children: consult
specialist for guidance on dose;
|
5 mg intravenously initially, may repeat in 10-15 min if no response, followed by 5-15 micrograms/min if response seen |
persistent respiratory symptoms |
children: 0.15 mg/kg nebulized every
20 minutes for 3 doses, then 0.15 to 0.3 mg/kg every 1-4 hours when required;
|
1.25 to 5 mg nebulized every 20 minutes for 3 doses, then every 1-4 hours when required |
symptomatic hives and rhinorrhoea
+
|
children: 1-2 mg/kg intravenously/intramuscularly;
children: 1 mg/kg intravenously given over 5 minutes;
|
25-50 mg intravenously/intramuscularly
50 mg
intravenously given over 5 minutes
|
post-emergency stabilisation |
children and adults: 1-2 mg/kg/day intravenouslychildren and adults: 0.5 to 1 mg/kg/day orally |
references:
Best Practice/BMJ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.